What Are the Current Outcomes of Advanced Gastrointestinal Stromal Tumors: Who Are the Long-Term Survivors Treated Initially With Imatinib?

Medical Oncology - United States
doi 10.1007/s12032-013-0765-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long-Term Adjuvant Treatment of Gastrointestinal Stromal Tumors (GIST) With Imatinib—a Comment and Reflection on the PERSIST-5 Study

Translational Gastroenterology and Hepatology
2018English

Gastrointestinal Stromal Tumors Treated With Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients

Radiology
Nuclear MedicineRadiologyImaging
2011English

Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage

Cancer
Cancer ResearchOncology
2018English

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2013English

Update on the Treatment of Gastrointestinal Stromal Tumors (GISTs): Role of Imatinib

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Are We Allowed to Limit Surgical Aggressiveness With Small Rectal Gastrointestinal Stromal Tumors?

Annals of Surgical Oncology
OncologySurgery
2016English

Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy
Gastroenterology
2009English

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated With Imatinib-Resistant Gastrointestinal Stromal Tumors

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy